Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CEP164: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CEP164 (Centrosomal Protein 164) is a key component of the centrosome and primary cilia, essential for ciliogenesis, cell cycle progression, and DNA damage response. Mutations cause nephronophthisis and related ciliopathies, with emerging links to neurodegenerative diseases.
No AI portrait yet
| Gene Symbol | CEP164 |
| Full Name | Centrosomal Protein 164 |
| Chromosome | 11q13.2 |
| Function | is a critical component of the centrosome and primary cilia, serving as a master regulator of ciliogenesis and cell cycle progression [graber2007](https://pubmed. |
| Subcellular Localization | ```mermaid |
| Molecular Weight | 164 kDa |
| Amino Acids | 1463 aa |
| Exons | 37 |
| Ensembl ID | ENSG00000110237 |
| GeneCards | CEP164 |
| Human Protein Atlas | CEP164 |
| Centrosome maturation | Promotes centrosome separation and maturation |
| Spindle assembly | Ensures proper mitotic spindle formation |
| G1/S transition | Controls entry into S phase |
| G2/M checkpoint | Participates in DNA damage checkpoints |
| Associated Diseases | neurodegeneration |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
CEP164["CEP164"]
neurodegeneration["neurodegeneration"]
CEP164 -->|"implicated in"| neurodegeneration
Neurodegenerative_Diseases{"Neurodegenerative Diseases"}
CEP164 -->|"implicated in"| Neurodegenerative_Diseases
Dna_Damage(["Dna Damage"])
CEP164 -->|"involved in"| Dna_Damage
ROS["ROS"]
CEP164 ---|"interacts"| ROS
style CEP164 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#fff
style Neurodegenerative_Diseases fill:#4a1a1a,stroke:#ef5350,stroke-width:1px,color:#ef5350
style Dna_Damage fill:#2a2a1a,stroke:#ffd54f,stroke-width:1px,color:#ffd54f| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CEP164 in their description or question text
No additional research found